HOME STORY OF OUR FIRM SEARCH
ASBESTOS DRUGS POLLUTANTS ACCIDENTS MALPRACTICE
English En Français

FREE LEGAL REVIEW

First Name
Last Name
Home Phone
Work Phone
City and State
Email
Were you diagnosed with Asbestosis? Yes
No
Were you diagnosed with lung cancer? Yes
No
Were you diagnosed with Mesothelioma? yes
no
What is your date of diagnosis?
Additional Comments
Best time to call?

Clinical Trials for Mesothelioma Patients: Immunotoxin Therapy Disease Characteristics

Read about the disease characteristics for a current clinical trial being conducted to study the effects of Immunotoxin Therapy for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At this time, the study is currently being conducted only in Zurich, Switzerland.

Disease Characteristics:
• Histologically confirmed epithelial pleural mesothelioma not amenable to potentially curative surgical resection
o Unresectable disease, defined as any 1 of the following:
Metastatic disease
Patient found at surgery not to be amenable to resection
Not to benefit from surgery due to extensive local disease or not a surgical candidate due to comorbid medical conditions as deemed by a qualified oncologist
• Measurable disease
• No documented and ongoing CNS involvement with malignant disease (history of CNS involvement is not an exclusion criterion)

Courtesy of ClinicalTrials.gov, a service of the U.S. National Institutes of Health

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney

Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos


IN THIS SECTION
Immunotoxin therapy for mesothelioma patients
Objectives of Immunotoxin trial on mesothelioma
Study outline for Immunotoxin mesothelioma trial
Disease traits in Immunotoxin mesothelioma trial
Patient traits: Immunotoxin mesothelioma trial
Contact info for Immunotoxin mesothelioma program


RETURN BACK TO
Mesothelioma
Treatment of Mesothelioma
Treatment
Clinical trials on asbestos illness: mesothelioma

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

see also:

Study outline for Immunotoxin mesothelioma trial Study outline for program to treat mesothelioma with Immunotoxin
Study outline for identifying effects of Immunotoxin on mesothelioma

Immunotoxin therapy for mesothelioma patients Therapy program to treat mesothelioma patients with Immunotoxin
Outcome measures for Immunotoxin therapy test on mesothelioma patients

Current Immunotoxin therapy: mesothelioma patients Current clinical trial of Immunotoxin therapy: mesothelioma patients
Immunotoxin may inhibit cancer cell growth in mesothelioma test